Decrease In Funding For Medical Research Can Have Serious Results – Part 2 of 3
This has caused the United States’ unalloyed share of global research funding – both public and private – to decline from 57 percent in 2004 to 44 percent in 2012, the appear noted. While the United States still maintains its preeminence in medical research, Asian countries threaten to take the lead. Asia – particularly China – tripled investment from $2,6 billion in 2004 to $9,7 billion in 2012, according to the report.
So “There’s no suspect we should be concerned about the US decline in global investment for medical research,” said Dr Victor Dzau, president of the Institute of Medicine of the National Academy of Sciences, who wrote an accompanying editorial. “In the administering we’re going, we’re going to lose our innovation and competitiveness globally”. Signs of slippage are beginning to show, the authors noted. China filed 30 percent of worldwide life science patent applications in 2011, compared with 24 percent from the United States.
From 1981 to 2011, the helping of “highly valuable” patents filed in the United States by American inventors decreased from 73 percent to 59 percent, while all other countries analyzed increased their share. Losing the spillway to patent new medical technologies could cost Americans tremendously. “Scientists tend to believe that science done anywhere can be applied anywhere, but in patented advances, the mobility across borders is often restricted due to deposition of those rights. If China or Singapore or India patents their innovations promiscuously and widely, it may limit applications, and certainly would increase the cost of those applications”.